Drug or chemical induced diabetes mellitus
Chapter 4:Endocrine, nutritional and metabolic diseases
ICD-10 E09 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus.
Drug or chemical induced diabetes mellitus (E09) refers to diabetes that arises as a direct consequence of pharmacological agents or toxic substances. This condition can be triggered by various medications, including glucocorticoids, antipsychotics, and certain chemotherapeutic agents. The pathophysiology involves the disruption of insulin secretion or action, leading to hyperglycemia. Patients may present with symptoms similar to those of type 2 diabetes, including polyuria, polydipsia, and unexplained weight loss. Management typically involves monitoring blood glucose levels, adjusting medications, and potentially initiating insulin therapy if necessary. Complications can include diabetic ketoacidosis, hyperglycemic hyperosmolar state, and long-term effects such as neuropathy, nephropathy, and retinopathy. Regular monitoring of HbA1c levels is crucial to assess glycemic control and adjust treatment plans accordingly. Understanding the specific drug or chemical responsible for the diabetes is essential for effective management and prevention of complications.
Detailed medication history, including dosage and duration.
Patients presenting with new-onset diabetes after starting a new medication.
Ensure clear documentation of the relationship between the drug and diabetes onset.
Record of psychiatric medications prescribed and their potential side effects.
Patients on antipsychotics developing diabetes.
Monitor metabolic side effects of medications closely.
Used for follow-up visits for patients with drug-induced diabetes.
Document the patient's medication history and current management plan.
Endocrinologists should focus on medication adjustments and monitoring.
Common medications that can induce diabetes include glucocorticoids, thiazide diuretics, and certain antipsychotics. It is essential to monitor blood glucose levels in patients starting these medications.
